Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Berlex continues legal challenge to FDA over MS drug.
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
Vision Disturbances in Multiple Sclerosis.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study.
Treatment satisfaction in multiple sclerosis.
Interferon-beta(1b) treatment in neuromyelitis optica.
Nanoparticle transport across the blood brain barrier.
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.
Rituximab (marketed as Rituxan), Information
Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies.
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Emerging oral agents for multiple sclerosis.
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a ...
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Clinical proteomics of enervated neurons.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.

Pages